Literature DB >> 23286298

A comparative study of flow cytometric T cell receptor Vβ repertoire and T cell receptor gene rearrangement in the diagnosis of large granular lymphocytic lymphoproliferation.

Y-C Hsieh1, S-T Chang, W-T Huang, S-Y Kuo, T-A Chiang, S-S Chuang.   

Abstract

INTRODUCTION: Large granular lymphocytes (LGLs) are medium- to large-sized lymphocytes with azurophilic cytoplasmic granules. Reactive vs. neoplastic LGLs are usually morphologically indistinguishable.
METHODS: We investigated 25 consecutive cases of LGL lymphoproliferation using flow cytometric T cell receptor Vβ (FC-Vβ) repertoire and T cell receptor gene rearrangement (TCR-GR) in detecting clonality.
RESULTS: Seventeen patients (68%) were T-LGL leukemia (T-LGLL) with a male predominance, a median age of 67, and a median absolute LGL count of 2.592 × 10(9) /L. All cases were clonal using the FC-Vβ analysis, and all but one (94%) was clonal by TCR-GR. Eight patients (32%) had reactive LGL lymphoproliferation. Two had EBV-associated infectious mononucleosis; one was clonal by both FC-Vβ and TCR-GR; and the other was clonal only by TCR-GR. The remaining six cases were polyclonal by both assays. Patients with reactive LGL lymphoproliferation were more frequently associated with an underlying/concurrent malignancy than those with T-LGLL (4/8 cases vs. 1/17; P = 0.023, Fisher's exact test). We compared the demographic, hemogram, and clonality data between these two groups and found that the only significant difference was the lower median platelet count in the LGL lymphocytosis group (201 × 10(9) /L vs. 223 × 10(9) /L; P = 0.031; Student's t-test). A literature review including the current study showed a high sensitivity of FC-Vβ analysis for T-LGLL (97.2%; 107/110 cases).
CONCLUSIONS: FC-Vβ analysis was slightly more sensitive than TCR-GR for the detection of clonal T cell lymphoproliferation. However, we must interpret the laboratory findings with clinical context as clonal T cell lymphoproliferation may occur in patients with viral infection.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Flow cytometry; T cell large granular lymphocytic leukemia; T cell receptor Vβ repertoire; Taiwan; immunophenotyping; large granular lymphocyte; large granular lymphocytic leukemia; lymphoproliferation

Mesh:

Substances:

Year:  2013        PMID: 23286298     DOI: 10.1111/ijlh.12041

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  5 in total

1.  Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.

Authors:  Ren-Ching Wang; Sheng-Tsung Chang; Yen-Chuan Hsieh; Wan-Ting Huang; Jeng-Dong Hsu; Chih-En Tseng; Ming-Chung Wang; Wei-Shou Hwang; John Wang; Shih-Sung Chuang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

2.  The Effect of Inhibitory Signals on the Priming of Drug Hapten-Specific T Cells That Express Distinct Vβ Receptors.

Authors:  Andrew Gibson; Lee Faulkner; Maike Lichtenfels; Monday Ogese; Zaid Al-Attar; Ana Alfirevic; Philipp R Esser; Stefan F Martin; Munir Pirmohamed; B Kevin Park; Dean J Naisbitt
Journal:  J Immunol       Date:  2017-07-07       Impact factor: 5.422

3.  Diagnosis of large granular lymphocytic leukemia in a patient previously treated for acute myeloblastic leukemia.

Authors:  Sinem Civriz Bozdag; Sinem Namdaroglu; Omur Kayikci; Gülsah Kaygusuz; Itir Demiriz; Murat Cinarsoy; Emre Tekgunduz; Fevzi Altuntas
Journal:  Hematol Rep       Date:  2013-12-23

4.  Massive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy.

Authors:  C Flores; T Wildes; B DiVita Dean; G Moore; J Drake; R Abraham; J Gil; O Yegorov; C Yang; J Dean; C Moneypenny; D Shin; C Pham; J Krauser; J King; G Grant; T Driscoll; J Kurtzberg; R McLendon; S Gururangan; D Mitchell
Journal:  Sci Adv       Date:  2019-11-27       Impact factor: 14.136

Review 5.  Large granular lymphocytosis after transplantation.

Authors:  Zhi-Yuan Qiu; Guang-Yu Tian; Zhao Zhang; Ye-Qing Zhang; Wei Xu; Jian-Yong Li
Journal:  Oncotarget       Date:  2017-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.